Variant report
Variant | nsv522496 |
---|---|
Chromosome Location | chr3:56197528-56206591 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000187672 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs11712407 | chr3:56197528-56197529 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs140387346 | chr3:56197529-56197530 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs543067040 | chr3:56197539-56197540 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs556482101 | chr3:56197542-56197543 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs150388323 | chr3:56197585-56197586 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs184697530 | chr3:56197631-56197632 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs545311352 | chr3:56197651-56197652 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs575807132 | chr3:56197661-56197662 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs527316057 | chr3:56197666-56197667 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs113329161 | chr3:56197704-56197705 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs370671580 | chr3:56197768-56197769 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs529756928 | chr3:56197778-56197779 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs549822252 | chr3:56197779-56197780 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs569770851 | chr3:56197820-56197821 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs2316477 | chr3:56197899-56197900 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs2316478 | chr3:56197929-56197930 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs138022624 | chr3:56197947-56197948 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs2316479 | chr3:56197998-56197999 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs142597388 | chr3:56198006-56198007 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs188314289 | chr3:56198007-56198008 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs2316480 | chr3:56198099-56198100 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs536369335 | chr3:56198134-56198135 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs556586698 | chr3:56198165-56198166 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs560530226 | chr3:56198201-56198202 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs576591402 | chr3:56198212-56198213 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs527695767 | chr3:56198246-56198247 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs558868139 | chr3:56198276-56198277 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs564017103 | chr3:56198332-56198333 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs552790010 | chr3:56198345-56198346 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs7636352 | chr3:56198361-56198362 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs191322578 | chr3:56198384-56198385 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs560744528 | chr3:56198396-56198397 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs550873613 | chr3:56198424-56198425 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs529659834 | chr3:56198432-56198433 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs7633985 | chr3:56198457-56198458 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs563374114 | chr3:56198461-56198462 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs532395529 | chr3:56198487-56198488 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs552392831 | chr3:56198497-56198498 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs7644153 | chr3:56198498-56198499 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs559489195 | chr3:56198518-56198519 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs183468540 | chr3:56198536-56198537 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs145958379 | chr3:56198575-56198576 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs536633840 | chr3:56198603-56198604 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs7644257 | chr3:56198612-56198613 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs374182754 | chr3:56198635-56198636 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs570130163 | chr3:56198636-56198637 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs538884424 | chr3:56198680-56198681 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs111475062 | chr3:56198737-56198738 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs572279992 | chr3:56198763-56198764 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs535004564 | chr3:56198826-56198827 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17133270 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Breast cancer | 21785460 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 16608533 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21509527 | CNVD |
Prostate cancer | 18632612 | CNVD |
Cancer | 20164919 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Breast cancer | 19490591 | CNVD |
Autism | 18414403 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Metastatic melanoma | 17975146 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:56192400-56204200 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
2 | chr3:56203400-56204600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
3 | chr3:56204000-56204400 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
4 | chr3:56204000-56204400 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
5 | chr3:56204000-56204400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
6 | chr3:56204200-56204400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
7 | chr3:56204400-56205800 | Weak transcription | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
8 | chr3:56204400-56206200 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
9 | chr3:56204400-56207200 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
10 | chr3:56205800-56207400 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
11 | chr3:56206200-56206400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
12 | chr3:56206400-56207200 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |